Human VEGF-A Monoclonal Antibody, Endotoxin 0.05 EU/mg

Artikelnummer: ABB-YR0136
Artikelname: Human VEGF-A Monoclonal Antibody, Endotoxin 0.05 EU/mg
Artikelnummer: ABB-YR0136
Hersteller Artikelnummer: YR0136
Alternativnummer: ABB-YR0136-20MG,ABB-YR0136-5MG
Hersteller: ABclonal
Kategorie: Antikörper
Applikation: ELISA, NeA
Immunogen: Human VEGF-A
Alternative Synonym: VPF, VEGF, MVCD1, L-VEGF
Brolucizumab is a monoclonal antibody indicated to treat neovascular age related macular degeneration. Brolucizumab is a vascular endothelial growth factor (VEGF) inhibitor which targets the major VEGF-A isoforms: VEGF110, VEGF121, and VEGF165. Inhibition of these VEGF-A isoforms reduce proliferation of endothelial cells, vascularization of the tissue, and permeability of the vasculature.
NCBI: 7422
UniProt: P15692
Reinheit: >95% Determined by SDS-PAGE
Target-Kategorie: VEGF-A
Application Verdünnung: In Vivo Grade Recombinant Human IgG1 Kappa Isotype Control Antibody
Anwendungsbeschreibung: Cross-Reactivity: <0.05EU/mg (<0.00005EU/µg) Determined by LAL gel clotting assay. ResearchArea: Cancer immunology